Table 2a Relationship between factors and overall survival in univariate analysis

From: Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

Variable

Category

Log-rank test ( P -value)

Age (years)

<43/43–65/>65

0.001

Sex

Male/female

0.866

Grade

High/low

0.002

Treatment

Surgery and RT±CT vs others

0.024

SEMA3A expression

Low/medium/high

0.091

SEMA3B expression

Low/medium/high

0.029

SEMA3C expression

Low/medium/high

0.613

SEMA3D expression

Low/medium/high

0.087

SEMA3E expression

Low/medium/high

0.091

SEMA3F expression

Low/medium/high

0.360

SEMA3G expression

Low/medium/high

0.016

SEMA4D expression

Low/medium/high

0.131

NPR1 expression

Low/medium/high

0.161

NPR2 expression

Low/medium/high

0.002

VEGF expression

Low/medium/high

0.012

  1. CT=chemotherapy; RT=radiotherapy.
  2. Gene expression was measured by quantitative real-time RT–PCR.